Millennium Management’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRPX
Millennium Management's VRPX Position: Q2 2025 in Review
Millennium Management sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q2 2025, closing a stake of 22,075 shares — an estimated $26.5K sold.
Millennium Management first reported a position in VRPX in Q1 2025 and held it in 1 quarter. The position peaked at $26.5K in Q1 2025. 1 fund tracked by Wall St. Rank holds VRPX as of Q2 2025.
- Millennium Management reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Millennium Management sold 22,075 Virpax Pharmaceuticals, Inc. Common Stock shares in Q2 2025, an estimated $26.5K.
- Millennium Management first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
- Millennium Management's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $26.5K in Q1 2025.
- 1 fund tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q2 2025.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.